Tecan Group (1TECN) Stock Overview

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. More details

1TECN fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	1/6
Financial Health	5/6
Dividends	5/6

Rewards

Trading at 40.9% below our estimate of its fair value

Earnings are forecast to grow 18.08% per year

Pays a reliable dividend of 1.95%

Risk Analysis

Profit margins (7%) are lower than last year (10.1%)

1TECN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Tecan Group AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tecan Group
Historical stock prices
Current Share Price	CHF 164.00
52 Week High	CHF 167.00
52 Week Low	CHF 156.00
Beta	0.97
1 Month Change	-2.38%
3 Month Change	-9.39%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-3.53%

Recent updates

Shareholder Returns

	1TECN	IT Life Sciences	IT Market
7D	3.1%	1.5%	1.3%
1Y	n/a	-4.0%	26.7%

Return vs Industry: Insufficient data to determine how 1TECN performed against the Italian Life Sciences industry.

Return vs Market: Insufficient data to determine how 1TECN performed against the Italian Market.

Price Volatility

Is 1TECN's price volatile compared to industry and market?
1TECN volatility
1TECN Average Weekly Movement	5.1%
Life Sciences Industry Average Movement	6.2%
Market Average Movement	4.3%
10% most volatile stocks in IT Market	7.9%
10% least volatile stocks in IT Market	2.5%

Stable Share Price: 1TECN has not had significant price volatility in the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1TECN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1980	3,000	Monica Manotas	www.tecan.com

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution.

Tecan Group AG Fundamentals Summary

How do Tecan Group's earnings and revenue compare to its market cap?
1TECN fundamental statistics
Market cap	€2.10b
Earnings (TTM)	€67.72m
Revenue (TTM)	€972.56m

30.9x

P/E Ratio

2.2x

P/S Ratio

Is 1TECN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1TECN income statement (TTM)
Revenue	CHF 906.60m
Cost of Revenue	CHF 587.57m
Gross Profit	CHF 319.03m
Other Expenses	CHF 255.90m
Earnings	CHF 63.13m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	4.97
Gross Margin	35.19%
Net Profit Margin	6.96%
Debt/Equity Ratio	19.5%

How did 1TECN perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

61%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/08 13:59
End of Day Share Price	2025/10/08 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tecan Group AG is covered by 26 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Volker Bosse	Baader Helvea Equity Research
Leonildo Delgado	Baader Helvea Equity Research
Markus Mayer	Baader Helvea Equity Research

Tecan Group AGBIT:1TECN Stock Report